SEC Form 4 · accession 0001104659-18-010366
RHYTHM PHARMACEUTICALS, INC. · RYTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leonardus H.T. Van der Ploeg
Officer — Chief Scientific Officer
Period of report
Feb 14, 2018
Accepted (ET)
Feb 16, 2018 · 4:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001649904
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $25.79 | Feb 14, 2018 | A | 55,000 | A | — | Feb 13, 2028 | Common Stock | 55,000 | 55,000 | D |
Explanation of responses
- F1This option was granted on February 14, 2018 and the shares underlying this option vest in sixteen equal quarterly installments.